SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-21-202051
Filing Date
2021-06-28
Accepted
2021-06-28 16:30:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 d134686ds1.htm S-1 724140
2 EX-1.1 d134686dex11.htm EX-1.1 146205
3 EX-5.1 d134686dex51.htm EX-5.1 6391
4 EX-23.1 d134686dex231.htm EX-23.1 1975
5 GRAPHIC g134686g0628085032183.jpg GRAPHIC 2836
6 GRAPHIC g134686g38a30.jpg GRAPHIC 79122
7 GRAPHIC g134686g94j64.jpg GRAPHIC 35104
  Complete submission text file 0001193125-21-202051.txt   1038024
Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-257476 | Film No.: 211053857
SIC: 2836 Biological Products, (No Diagnostic Substances)